Antibiotic Treatment of Staphylococcal Infections in Adults

Community-acquired cutaneous infections (non-MRSA)

 Penicillin-allergic patients

Community-acquired cutaneous infections likely to be due to MRSA

 Sulfa-allergic patients

Serious infections unlikely to be due to MRSA

 Penicillin-allergic patients

Serious infection highly likely to be due to MRSA

Ceftobiprole 500 mg IV every 8 hours (not available in the United States)

Documented MRSA

By reported sensitivities

Quinupristin/dalfopristin 7.5 mg/kg every 8 hours

Ceftobiprole 500 mg IV every 8 hours (not available in the United States)